Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Predictive Value of Ov16 Antibody Prevalence in Different Sub-Populations for Elimination of African Onchocerciasis.

Coffeng LE, Stolk WA, Golden A, de Los Santos T, Domingo GJ, de Vlas SJ.

Am J Epidemiol. 2019 May 7. pii: kwz109. doi: 10.1093/aje/kwz109. [Epub ahead of print]

PMID:
31062838
2.

An experimental human blood stage model for studying Plasmodium malariae infection.

Woodford J, Collins KA, Odedra A, Wang C, Kyung JI, Domingo GJ, Watts R, Marquart L, Berriman M, Otto TD, McCarthy JS.

J Infect Dis. 2019 Mar 10. pii: jiz102. doi: 10.1093/infdis/jiz102. [Epub ahead of print]

PMID:
30852586
3.
4.

Simultaneous Quantification of Plasmodium Antigens and Host Factor C-Reactive Protein in Asymptomatic Individuals with Confirmed Malaria by Use of a Novel Multiplex Immunoassay.

Jang IK, Tyler A, Lyman C, Kahn M, Kalnoky M, Rek JC, Arinaitwe E, Adrama H, Murphy M, Imwong M, Ling CL, Proux S, Haohankhunnatham W, Rist M, Seilie AM, Hanron A, Daza G, Chang M, Das S, Barney R, Rashid A, Landier J, Boyle DS, Murphy SC, McCarthy JS, Nosten F, Greenhouse B, Domingo GJ.

J Clin Microbiol. 2019 Jan 2;57(1). pii: e00948-18. doi: 10.1128/JCM.00948-18. Print 2019 Jan.

5.

A new highly sensitive enzyme-linked immunosorbent assay for the detection of Plasmodium falciparum histidine-rich protein 2 in whole blood.

Jang IK, Das S, Barney RS, Peck RB, Rashid A, Proux S, Arinaitwe E, Rek J, Murphy M, Bowers K, Boadi S, Watson J, Nosten F, Greenhouse B, Chiodini PL, Domingo GJ.

Malar J. 2018 Nov 1;17(1):403. doi: 10.1186/s12936-018-2545-5.

6.

Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.

Pal S, Bansil P, Bancone G, Hrutkay S, Kahn M, Gornsawun G, Penpitchaporn P, Chu CS, Nosten F, Domingo GJ.

Am J Trop Med Hyg. 2019 Jan;100(1):213-221. doi: 10.4269/ajtmh.18-0612.

7.

Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities.

Domingo GJ, Advani N, Satyagraha AW, Sibley CH, Rowley E, Kalnoky M, Cohen J, Parker M, Kelley M.

Int Health. 2019 Jan 1;11(1):7-14. doi: 10.1093/inthealth/ihy060.

8.

Operational Performance of a Plasmodium falciparum Ultrasensitive Rapid Diagnostic Test for Detection of Asymptomatic Infections in Eastern Myanmar.

Landier J, Haohankhunnatham W, Das S, Konghahong K, Christensen P, Raksuansak J, Phattharakokoedbun P, Kajeechiwa L, Thwin MM, Jang IK, Imwong M, Wiladphaingern J, Lwin KM, Ling C, Proux S, Domingo GJ, Delmas G, Nosten FH.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00565-18. doi: 10.1128/JCM.00565-18. Print 2018 Aug.

9.

Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.

Bancone G, Gornsawun G, Chu CS, Porn P, Pal S, Bansil P, Domingo GJ, Nosten F.

PLoS One. 2018 May 8;13(5):e0196716. doi: 10.1371/journal.pone.0196716. eCollection 2018.

10.

Performance of an ultra-sensitive Plasmodium falciparum HRP2-based rapid diagnostic test with recombinant HRP2, culture parasites, and archived whole blood samples.

Das S, Peck RB, Barney R, Jang IK, Kahn M, Zhu M, Domingo GJ.

Malar J. 2018 Mar 17;17(1):118. doi: 10.1186/s12936-018-2268-7. Erratum in: Malar J. 2019 Feb 4;18(1):33.

11.

Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression.

Kalnoky M, Bancone G, Kahn M, Chu CS, Chowwiwat N, Wilaisrisak P, Pal S, LaRue N, Leader B, Nosten F, Domingo GJ.

Eur J Haematol. 2018 Mar;100(3):294-303. doi: 10.1111/ejh.13013. Epub 2018 Jan 15.

12.

Methods for the field evaluation of quantitative G6PD diagnostics: a review.

Ley B, Bancone G, von Seidlein L, Thriemer K, Richards JS, Domingo GJ, Price RN.

Malar J. 2017 Sep 11;16(1):361. doi: 10.1186/s12936-017-2017-3. Review.

13.

The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.

Bancone G, Kalnoky M, Chu CS, Chowwiwat N, Kahn M, Malleret B, Wilaisrisak P, Rénia L, Domingo GJ, Nosten F.

Sci Rep. 2017 Aug 29;7(1):9822. doi: 10.1038/s41598-017-10045-2.

14.

Performance of a High-Sensitivity Rapid Diagnostic Test for Plasmodium falciparum Malaria in Asymptomatic Individuals from Uganda and Myanmar and Naive Human Challenge Infections.

Das S, Jang IK, Barney B, Peck R, Rek JC, Arinaitwe E, Adrama H, Murphy M, Imwong M, Ling CL, Proux S, Haohankhunnatham W, Rist M, Seilie AM, Hanron A, Daza G, Chang M, Nakamura T, Kalnoky M, Labarre P, Murphy SC, McCarthy JS, Nosten F, Greenhouse B, Allauzen S, Domingo GJ.

Am J Trop Med Hyg. 2017 Nov;97(5):1540-1550. doi: 10.4269/ajtmh.17-0245. Epub 2017 Aug 18.

15.

Biolayer interferometry predicts ELISA performance of monoclonal antibody pairs for Plasmodium falciparum histidine-rich protein 2.

Markwalter CF, Jang IK, Burton RA, Domingo GJ, Wright DW.

Anal Biochem. 2017 Oct 1;534:10-13. doi: 10.1016/j.ab.2017.07.010. Epub 2017 Jul 8.

16.

Current and cumulative malaria infections in a setting embarking on elimination: Amhara, Ethiopia.

Yalew WG, Pal S, Bansil P, Dabbs R, Tetteh K, Guinovart C, Kalnoky M, Serda BA, Tesfay BH, Beyene BB, Seneviratne C, Littrell M, Yokobe L, Noland GS, Domingo GJ, Getachew A, Drakeley C, Steketee RW.

Malar J. 2017 Jun 8;16(1):242. doi: 10.1186/s12936-017-1884-y.

17.

Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency.

Kahn M, LaRue N, Zhu C, Pal S, Mo JS, Barrett LK, Hewitt SN, Dumais M, Hemmington S, Walker A, Joynson J, Leader BT, Van Voorhis WC, Domingo GJ.

PLoS One. 2017 May 26;12(5):e0177885. doi: 10.1371/journal.pone.0177885. eCollection 2017.

18.

Multiplex, DNase-free one-step reverse transcription PCR for Plasmodium 18S rRNA and spliced gametocyte-specific mRNAs.

Hanron AE, Billman ZP, Seilie AM, Olsen TM, Fishbaugher M, Chang M, Rueckle T, Andenmatten N, Greenhouse B, Arinaitwe E, Rek J, Das S, Domingo GJ, Shipman K, Kappe SH, Kublin JG, Murphy SC.

Malar J. 2017 May 19;16(1):208. doi: 10.1186/s12936-017-1863-3.

19.

Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.

Thriemer K, Ley B, Bobogare A, Dysoley L, Alam MS, Pasaribu AP, Sattabongkot J, Jambert E, Domingo GJ, Commons R, Auburn S, Marfurt J, Devine A, Aktaruzzaman MM, Sohel N, Namgay R, Drukpa T, Sharma SN, Sarawati E, Samad I, Theodora M, Nambanya S, Ounekham S, Mudin RN, Da Thakur G, Makita LS, Deray R, Lee SE, Boaz L, Danansuriya MN, Mudiyanselage SD, Chinanonwait N, Kitchakarn S, Nausien J, Naket E, Duc TN, Do Manh H, Hong YS, Cheng Q, Richards JS, Kusriastuti R, Satyagraha A, Noviyanti R, Ding XC, Khan WA, Swe Phru C, Guoding Z, Qi G, Kaneko A, Miotto O, Nguitragool W, Roobsoong W, Battle K, Howes RE, Roca-Feltrer A, Duparc S, Bhowmick IP, Kenangalem E, Bibit JA, Barry A, Sintasath D, Abeyasinghe R, Sibley CH, McCarthy J, von Seidlein L, Baird JK, Price RN.

Malar J. 2017 Apr 5;16(1):141. doi: 10.1186/s12936-017-1784-1. Review.

20.

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.

Lont YL, Coffeng LE, de Vlas SJ, Golden A, de Los Santos T, Domingo GJ, Stolk WA.

PLoS Negl Trop Dis. 2017 Jan 23;11(1):e0005314. doi: 10.1371/journal.pntd.0005314. eCollection 2017 Jan.

21.

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

Golden A, Faulx D, Kalnoky M, Stevens E, Yokobe L, Peck R, Karabou P, Banla M, Rao R, Adade K, Gantin RG, Komlan K, Soboslay PT, de Los Santos T, Domingo GJ.

Parasit Vectors. 2016 Jun 13;9(1):338. doi: 10.1186/s13071-016-1623-1.

22.

Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.

Oo NN, Bancone G, Maw LZ, Chowwiwat N, Bansil P, Domingo GJ, Htun MM, Thant KZ, Htut Y, Nosten F.

PLoS One. 2016 Apr 1;11(4):e0152304. doi: 10.1371/journal.pone.0152304. eCollection 2016.

23.

Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.

Satyagraha AW, Sadhewa A, Elvira R, Elyazar I, Feriandika D, Antonjaya U, Oyong D, Subekti D, Rozi IE, Domingo GJ, Harahap AR, Baird JK.

PLoS Negl Trop Dis. 2016 Feb 19;10(2):e0004457. doi: 10.1371/journal.pntd.0004457. eCollection 2016 Feb.

24.

A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.

Golden A, Stevens EJ, Yokobe L, Faulx D, Kalnoky M, Peck R, Valdez M, Steel C, Karabou P, Banla M, Soboslay PT, Adade K, Tekle AH, Cama VA, Fischer PU, Nutman TB, Unnasch TR, de los Santos T, Domingo GJ.

PLoS Negl Trop Dis. 2016 Jan 8;10(1):e0004292. doi: 10.1371/journal.pntd.0004292. eCollection 2016 Jan.

25.

Methodology for preservation of yeast-bound single chain fragment variable antibody affinity reagents.

Kahn M, Priddy S, Estrada M, Spadafora L, Cangelosi GA, Domingo GJ.

J Immunol Methods. 2015 Dec;427:134-7. doi: 10.1016/j.jim.2015.11.003. Epub 2015 Nov 10.

26.

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

Ley B, Luter N, Espino FE, Devine A, Kalnoky M, Lubell Y, Thriemer K, Baird JK, Poirot E, Conan N, Kheong CC, Dysoley L, Khan WA, Dion-Berboso AG, Bancone G, Hwang J, Kumar R, Price RN, von Seidlein L, Domingo GJ.

Malar J. 2015 Sep 29;14:377. doi: 10.1186/s12936-015-0896-8.

27.

Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection.

Steel C, Golden A, Stevens E, Yokobe L, Domingo GJ, de los Santos T, Nutman TB.

Clin Vaccine Immunol. 2015 Aug;22(8):896-901. doi: 10.1128/CVI.00227-15. Epub 2015 May 27.

28.

Maintaining Specimen Integrity for G6PD Screening by Cytofluorometric Assays.

Kahn M, Ward WH, LaRue N, Kalnoky M, Pal S, Domingo GJ.

J Histochem Cytochem. 2015 Jun;63(6):454-8. doi: 10.1369/0022155415580594. Epub 2015 Mar 18. Erratum in: J Histochem Cytochem. 2016 Jun;64(6):394.

29.

Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests.

Bancone G, Chu CS, Chowwiwat N, Somsakchaicharoen R, Wilaisrisak P, Charunwatthana P, Bansil P, McGray S, Domingo GJ, Nosten FH.

Am J Trop Med Hyg. 2015 Apr;92(4):818-824. doi: 10.4269/ajtmh.14-0696. Epub 2015 Feb 2.

30.

Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency.

LaRue N, Kahn M, Murray M, Leader BT, Bansil P, McGray S, Kalnoky M, Zhang H, Huang H, Jiang H, Domingo GJ.

Am J Trop Med Hyg. 2014 Oct;91(4):854-861. doi: 10.4269/ajtmh.14-0194. Epub 2014 Jul 28.

31.

G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.

Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, Carter N, Cheng Q, Culpepper J, Eziefula C, Fukuda M, Green J, Hwang J, Lacerda M, McGray S, Menard D, Nosten F, Nuchprayoon I, Oo NN, Bualombai P, Pumpradit W, Qian K, Recht J, Roca A, Satimai W, Sovannaroth S, Vestergaard LS, Von Seidlein L.

Malar J. 2013 Nov 4;12:391. doi: 10.1186/1475-2875-12-391.

33.

Extended result reading window in lateral flow tests detecting exposure to Onchocerca volvulus: a new technology to improve epidemiological surveillance tools.

Golden A, Steel C, Yokobe L, Jackson E, Barney R, Kubofcik J, Peck R, Unnasch TR, Nutman TB, de los Santos T, Domingo GJ.

PLoS One. 2013 Jul 23;8(7):e69231. doi: 10.1371/journal.pone.0069231. Print 2013.

34.

Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis.

Steel C, Golden A, Kubofcik J, LaRue N, de Los Santos T, Domingo GJ, Nutman TB.

Clin Vaccine Immunol. 2013 Aug;20(8):1155-61. doi: 10.1128/CVI.00252-13. Epub 2013 Jun 5.

35.

A Rapid, Multiplexed, High-Throughput Flow-Through Membrane Immunoassay: A Convenient Alternative to ELISA.

Ramachandran S, Singhal M, McKenzie KG, Osborn JL, Arjyal A, Dongol S, Baker SG, Basnyat B, Farrar J, Dolecek C, Domingo GJ, Yager P, Lutz B.

Diagnostics (Basel). 2013 Apr 2;3(2):244-60. doi: 10.3390/diagnostics3020244.

36.

Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis.

Schito M, Peter TF, Cavanaugh S, Piatek AS, Young GJ, Alexander H, Coggin W, Domingo GJ, Ellenberger D, Ermantraut E, Jani IV, Katamba A, Palamountain KM, Essajee S, Dowdy DW.

J Infect Dis. 2012 May 15;205 Suppl 2:S169-80. doi: 10.1093/infdis/jis044. Epub 2012 Mar 29.

37.

Post-extraction stabilization of HIV viral RNA for quantitative molecular tests.

Stevens DS, Crudder CH, Domingo GJ.

J Virol Methods. 2012 Jun;182(1-2):104-10. doi: 10.1016/j.jviromet.2012.03.006. Epub 2012 Mar 13.

38.

Perspectives on introduction and implementation of new point-of-care diagnostic tests.

Palamountain KM, Baker J, Cowan EP, Essajee S, Mazzola LT, Metzler M, Schito M, Stevens WS, Young GJ, Domingo GJ.

J Infect Dis. 2012 May 15;205 Suppl 2:S181-90. doi: 10.1093/infdis/jis203. Epub 2012 Mar 7.

39.

Toward low-cost affinity reagents: lyophilized yeast-scFv probes specific for pathogen antigens.

Gray SA, Weigel KM, Ali IK, Lakey AA, Capalungan J, Domingo GJ, Cangelosi GA.

PLoS One. 2012;7(2):e32042. doi: 10.1371/journal.pone.0032042. Epub 2012 Feb 20.

40.

Malaria prevalence defined by microscopy, antigen detection, DNA amplification and total nucleic acid amplification in a malaria-endemic region during the peak malaria transmission season.

Waitumbi JN, Gerlach J, Afonina I, Anyona SB, Koros JN, Siangla J, Ankoudinova I, Singhal M, Watts K, Polhemus ME, Vermeulen NM, Mahoney W, Steele M, Domingo GJ.

Trop Med Int Health. 2011 Jul;16(7):786-93. doi: 10.1111/j.1365-3156.2011.02773.x. Epub 2011 Mar 29.

41.

Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low-HIV prevalence, low-resource setting.

Gerlach J, Sequeira M, Alvarado V, Cerpas C, Balmaseda A, Gonzalez A, de Los Santos T, Levin CE, Amador JJ, Domingo GJ.

J Int AIDS Soc. 2010 Nov 5;13:43. doi: 10.1186/1758-2652-13-43.

42.

Outpatient upper respiratory tract viral infections in children with malaria symptoms in Western Kenya.

Waitumbi JN, Kuypers J, Anyona SB, Koros JN, Polhemus ME, Gerlach J, Steele M, Englund JA, Neuzil KM, Domingo GJ.

Am J Trop Med Hyg. 2010 Nov;83(5):1010-3. doi: 10.4269/ajtmh.2010.10-0174.

43.

HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells.

Caivano A, Doria-Rose NA, Buelow B, Sartorius R, Trovato M, D'Apice L, Domingo GJ, Sutton WF, Haigwood NL, De Berardinis P.

Virology. 2010 Nov 25;407(2):296-305. doi: 10.1016/j.virol.2010.08.026. Epub 2010 Sep 20.

44.

Laboratory operations, specimen processing, and handling for viral load testing and surveillance.

Puren A, Gerlach JL, Weigl BH, Kelso DM, Domingo GJ.

J Infect Dis. 2010 Apr 15;201 Suppl 1:S27-36. doi: 10.1086/650390. Review.

PMID:
20225943
45.

Point-of-care diagnostics for global health.

Yager P, Domingo GJ, Gerdes J.

Annu Rev Biomed Eng. 2008;10:107-44. doi: 10.1146/annurev.bioeng.10.061807.160524. Review.

PMID:
18358075
46.

Compositionally and functionally distinct editosomes in Trypanosoma brucei.

Panigrahi AK, Ernst NL, Domingo GJ, Fleck M, Salavati R, Stuart KD.

RNA. 2006 Jun;12(6):1038-49. Epub 2006 Apr 12.

47.

Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta.

Fried M, Domingo GJ, Gowda CD, Mutabingwa TK, Duffy PE.

Exp Parasitol. 2006 May;113(1):36-42. Epub 2006 Jan 23.

PMID:
16430888
48.

Maternal malaria and gravidity interact to modify infant susceptibility to malaria.

Mutabingwa TK, Bolla MC, Li JL, Domingo GJ, Li X, Fried M, Duffy PE.

PLoS Med. 2005 Dec;2(12):e407. Epub 2005 Nov 8.

49.

Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection.

De Berardinis P, Sartorius R, Caivano A, Mascolo D, Domingo GJ, Del Pozzo G, Gaubin M, Perham RN, Piatier-Tonneau D, Guardiola J.

Curr HIV Res. 2003 Oct;1(4):441-6.

PMID:
15049429
50.

Dyskinetoplastic Trypanosoma brucei contains functional editing complexes.

Domingo GJ, Palazzo SS, Wang B, Pannicucci B, Salavati R, Stuart KD.

Eukaryot Cell. 2003 Jun;2(3):569-77.

Supplemental Content

Loading ...
Support Center